A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction

Current Biology

Volumn 15, Issue 1, 2005, Pages 73-78

  Yap, Melvyn W ^a   Nisole, Sébastien ^a   Stoye, Jonathan P ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARRIER PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TRIM5 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; ARTICLE; COMPARATIVE STUDY; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GENETICS; HAPLORHINI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CARRIER PROTEINS; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HAPLORHINI; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MACACA MULATTA; MAMMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 11844278251     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.12.042     Document Type: Article

References (34)

1. Bieniasz P.D. Restriction factors. a defense against retroviral infection Trends Microbiol. 11:2003;286-291
2. Goff S.P. Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. 38:2004;61-85. Published online May 26, 2004. 10.1146/annurev.genet.38.072902.094136
3. Stoye J.P. An intracellular block to primate lentivirus replication. Proc. Natl. Acad. Sci. USA. 99:2002;11549-11551
4. Lilly F. Fv-2. identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice J. Natl. Cancer Inst. 45:1970;163-169
5. Best S., Le Tissier P., Towers G., Stoye J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature. 382:1996;826-829
6. Stevens A., Bock M., Ellis S., LeTissier P., Bishop K.N., Yap M.W., Taylor W., Stoye J.P. Retroviral capsid determinants of Fv1 NB and NR tropism. J. Virol. 78:2004;9592-9598
7. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J.P., Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA. 97:2000;12295-12299
8. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA. 99:2002;11914-11919
9. Besnier C., Takeuchi Y., Towers G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA. 99:2002;11920-11925
10. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427:2004;848-853
11. Hatziioannou T., Perez-Caballero D., Yang A., Cowan S., Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. USA. 101:2004;10774-10779
12. Keckesova Z., Ylinen L.M., Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. USA. 101:2004;10780-10785
13. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. USA. 101:2004;10786-10791
14. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. USA. 101:2004;11827-11832
15. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., et al. The tripartite motif family identifies cell compartments. EMBO J. 20:2001;2140-2151
16. Bock M., Bishop K.N., Towers G., Stoye J.P. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J. Virol. 74:2000;7422-7430
17. Buchner G., Montini E., Andolfi G., Quaderi N., Cainarca S., Messali S., Bassi M.T., Ballabio A., Meroni G., Franco B. MID2, a homologue of the Opitz syndrome gene MID1. similarities in subcellular localization and differences in expression during development Hum. Mol. Genet. 8:1999;1397-1407
18. Perry J., Short K.M., Romer J.T., Swift S., Cox T.C., Ashworth A. FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules. Genomics. 62:1999;385-394
19. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 430:2004;569-573
20. Nisole S., Lynch C., Stoye J.P., Yap M.W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA. 101:2004;13324-13328
21. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9:2003;1138-1143
22. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078
23. Ponting C., Schultz J., Bork P. SPRY domains in ryanodine receptors (Ca(2+)-release channels). Trends Biochem. Sci. 22:1997;193-194
24. Seto M.H., Liu H.L., Zajchowski D.A., Whitlow M. Protein fold analysis of the B30.2-like domain. Proteins. 35:1999;235-249
25. Quaderi N.A., Schweiger S., Gaudenz K., Franco B., Rugarli E.I., Berger W., Feldman G.J., Volta M., Andolfi G., Gilgenkrantz S., et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet. 17:1997;285-291
26. Gaudenz K., Roessler E., Quaderi N., Franco B., Feldman G., Gasser D.L., Wittwer B., Horst J., Montini E., Opitz J.M., et al. Opitz G/BBB syndrome in Xp22. mutations in the MID1 gene cluster in the carboxy-terminal domain Am. J. Hum. Genet. 63:1998;703-710
27. Consortium T.F.F. A candidate gene for familial Mediterranean fever. Nat. Genet. 17:1997;25-31
28. Consortium T.I.F. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 90:1997;797-807
29. Ashley-Koch A., Yang Q., Olney R.S. Sickle hemoglobin (HbS) allele and sickle cell disease. a HuGE review Am. J. Epidemiol. 151:2000;839-845
30. Gao F., Bailes E., Robertson D.L., Chen Y., Rodenburg C.M., Michael S.F., Cummins L.B., Arthur L.O., Peeters M., Shaw G.M., et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 397:1999;436-441
31. Bogerd H.P., Doehle B.P., Wiegand H.L., Cullen B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA. 101:2004;3770-3774
32. Schrofelbauer B., Chen D., Landau N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA. 101:2004;3927-3932
33. Xu H., Svarovskaia E.S., Barr R., Zhang Y., Khan M.A., Strebel K., Pathak V.K. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA. 101:2004;5652-5657
34. Humeau L.M., Binder G.K., Lu X., Slepushkin V., Merling R., Echeagaray P., Pereira M., Slepushkina T., Barnett S., Dropulic L.K., et al. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol. Ther. 9:2004;902-913